These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8725761)

  • 21. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol.
    Kaufman RH; Adam E; Binder GL; Gerthoffer E
    Am J Obstet Gynecol; 1980 Jun; 137(3):299-308. PubMed ID: 7377249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound detection of uterine abnormalities after diethylstilbestrol (DES) exposure.
    Viscomi GN; Gonzalez R; Taylor KJ
    Radiology; 1980 Sep; 136(3):733-5. PubMed ID: 7403556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diethylstilbestrol (DES): also harms the third generation.
    Prescrire Int; 2016 Dec; 25(177):294-298. PubMed ID: 30758926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny.
    Kaufman RH; Noller K; Adam E; Irwin J; Gray M; Jefferies JA; Hilton J
    Am J Obstet Gynecol; 1984 Apr; 148(7):973-84. PubMed ID: 6711635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography.
    Pellerito JS; McCarthy SM; Doyle MB; Glickman MG; DeCherney AH
    Radiology; 1992 Jun; 183(3):795-800. PubMed ID: 1584936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.
    Wise LA; Palmer JR; Rowlings K; Kaufman RH; Herbst AL; Noller KL; Titus-Ernstoff L; Troisi R; Hatch EE; Robboy SJ
    Obstet Gynecol; 2005 Jan; 105(1):167-73. PubMed ID: 15625159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at natural menopause in women exposed to diethylstilbestrol in utero.
    Hatch EE; Troisi R; Wise LA; Hyer M; Palmer JR; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Adam E; Noller KL; Herbst AL; Robboy S; Hartge P; Hoover RN
    Am J Epidemiol; 2006 Oct; 164(7):682-8. PubMed ID: 16887893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of DES.
    Kruse K; Lauver D; Hanson K
    Nurse Pract; 2003 Jul; 28(7 Pt 1):26-32,35, table of contents; quiz 35-7. PubMed ID: 12861092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.
    Kaufman RH; Adam E; Hatch EE; Noller K; Herbst AL; Palmer JR; Hoover RN
    Obstet Gynecol; 2000 Oct; 96(4):483-9. PubMed ID: 11004345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fallopian tubal patency diagnosed by magnetic resonance hysterosalpingography.
    Ma L; Wu G; Wang Y; Zhang Y; Wang J; Li L; Zhou W
    J Reprod Med; 2012; 57(9-10):435-40. PubMed ID: 23091993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences.
    Herbst AL; Anderson D
    AMA J Ethics; 2015 Sep; 17(9):865-70. PubMed ID: 26390210
    [No Abstract]   [Full Text] [Related]  

  • 32. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
    Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
    Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genital tract anomalies associated with in utero exposure to diethylstilbestrol.
    Kaufman RH; Adam E
    Isr J Med Sci; 1978 Mar; 14(3):353-62. PubMed ID: 640820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation.
    Huang WW; Yin Y; Bi Q; Chiang TC; Garner N; Vuoristo J; McLachlan JA; Ma L
    Mol Endocrinol; 2005 Mar; 19(3):669-82. PubMed ID: 15591538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DES up close.
    Rosen F
    Nurse Pract; 2003 Jul; 28(7 Pt 1):34. PubMed ID: 12861093
    [No Abstract]   [Full Text] [Related]  

  • 37. Intractable primary infertility in women exposed to diethylstilbestrol in utero.
    Berger MJ; Alper MM
    J Reprod Med; 1986 Apr; 31(4):231-5. PubMed ID: 3712361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive significance of changes in the endometrial cavity associated with exposure in utero to diethylstilbestrol.
    Pillsbury SG
    Am J Obstet Gynecol; 1980 May; 137(2):178-82. PubMed ID: 7377238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DES exposure: implications for childbearing.
    Milhan D
    Int J Childbirth Educ; 1992; 7(4):21-8. PubMed ID: 12286762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of enlargement uteroplasty in the treatment of uterine anomalies following exposure to diethylstillbestrol (May 2003)].
    Aubriot FX; Audebert A; Blanc B; Dechaud H; Elpelboin S; Fernandez H; Garbin O; Hamou J; Landowski P; Paniel BJ; Tournaire M; Salle B; Mergui JL;
    Gynecol Obstet Fertil; 2004 Mar; 32(3):261-4; discussion 261. PubMed ID: 15123126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.